^“Consecutive actions of different gene-altering mechanisms in the evolution of involucrin”. Molecular Biology and Evolution9 (6): 977–1017. (November 1992). doi:10.1093/oxfordjournals.molbev.a040775. PMID1359382.
^“Roxithromycin suppresses involucrin expression by modulation of activator protein-1 and nuclear factor-kappaB activities of keratinocytes”. Journal of Dermatological Science39 (3): 175–82. (September 2005). doi:10.1016/j.jdermsci.2005.03.006. PMID16140218.
^“Apigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cdelta Tyr311”. The Journal of Biological Chemistry281 (47): 36162–72. (November 2006). doi:10.1074/jbc.M605368200. PMID16982614.
“Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity”. The Journal of Biological Chemistry270 (21): 12614–22. (May 1995). doi:10.1074/jbc.270.21.12614. PMID7759510.
“Physical mapping of a functional cluster of epidermal differentiation genes on chromosome 1q21”. Genomics18 (1): 92–9. (October 1993). doi:10.1006/geno.1993.1430. PMID8276421.
“Analysis of the 5'-upstream promoter region of human involucrin gene: activation by 12-O-tetradecanoylphorbol-13-acetate”. The Journal of Investigative Dermatology100 (1): 10–5. (January 1993). doi:10.1111/1523-1747.ep12349867. PMID8380829.
“Transcriptional analysis of the 5'-noncoding region of the human involucrin gene”. The Journal of Biological Chemistry271 (1): 512–20. (January 1996). doi:10.1074/jbc.271.1.512. PMID8550612.
“Repression of involucrin gene expression by transcriptional enhancer factor 1 (TEF-1)”. Archives of Dermatological Research287 (8): 740–6. (1995). doi:10.1007/BF01105799. PMID8554386.
“Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified cell envelope”. The Journal of Biological Chemistry272 (3): 2021–30. (January 1997). doi:10.1074/jbc.272.3.2021. PMID8999895.
“S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes”. The Journal of Biological Chemistry272 (18): 12035–46. (May 1997). doi:10.1074/jbc.272.18.12035. PMID9115270.
“Regulation of involucrin gene expression by calcium in normal human keratinocytes”. Frontiers in Bioscience1: a16-24. (January 1996). doi:10.2741/A101. PMID9159190.
“Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope”. The Journal of Biological Chemistry273 (28): 17763–70. (July 1998). doi:10.1074/jbc.273.28.17763. PMID9651377.
“The distal regulatory region of the human involucrin promoter is required for expression in epidermis”. The Journal of Biological Chemistry273 (46): 30460–5. (November 1998). doi:10.1074/jbc.273.46.30460. PMID9804813.
“Small proline-rich protein 1 is the major component of the cell envelope of normal human oral keratinocytes”. FEBS Letters477 (3): 268–72. (July 2000). doi:10.1016/S0014-5793(00)01806-8. PMID10908733.
“Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro”. The Journal of Biological Chemistry276 (37): 35014–23. (September 2001). doi:10.1074/jbc.M010157200. PMID11443109.
“The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation”. Oncogene21 (5): 738–47. (January 2002). doi:10.1038/sj.onc.1205038. PMID11850802.